Jingqian Qin

Mrs. Jingqian Qin


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2026 in Medicine
Verified
Journal Article
Open access
SLShuang Mb Liu
Shuang Mb Liu
MQMengjie Mb Qin
Mengjie Mb Qin
XZXiying Zhou
Xiying Zhou
FAFenghua Mb Ai
Fenghua Mb Ai
JQJingqian Qin
Jingqian Qin
Dietary fiber intake is linked to metabolic health, yet its association with liver fibrosis, particularly across different fiber sources, remains incompletely understood. This study aims to assess the relationship between dietary fiber from various sources and liver fibrosis in Unites States National Health And Nutrition Examination Survey adults. We used data from National Health and Nutrition Examination Survey 2017 to 2020, examining the associations between dietary fiber intake and liver fibrosis assessed by transient elastography in a nationally representative sample of United States adults. Dietary fiber intake, including total fiber and fiber from fruits, vegetables, grains, and legumes, was assessed using 24-hour dietary recalls. Liver fibrosis was evaluated using both continuous liver stiffness measurements and a categorical definition of significant fibrosis (median liver stiffness ≥ 8 kPa). Survey-weighted linear and logistic regression models were applied, adjusting for sociodemographic characteristics, lifestyle behaviors, metabolic comorbidities, and total energy intake. After multivariable adjustment, higher intake of fruit-derived dietary fiber was consistently associated with lower liver stiffness ( β = −0.13, 95% confidence interval: −0.22 to −0.04). Compared with the lowest quartile, participants in the highest quartile of fruit fiber intake had significantly lower odds of significant liver fibrosis (odds ratio = 0.61, 95% confidence interval: 0.45–0.83). In contrast, total dietary fiber and fiber from vegetables, grains, and legumes showed weaker or less consistent associations, and no clear monotonic dose-response relationships were observed. These findings suggest that the source of dietary fiber, particularly fruit-derived fiber, may be more relevant than total fiber intake alone in relation to liver fibrosis risk. This study emphasizes the clinical importance of fiber sources in liver fibrosis management and supports further prospective studies to clarify causality.

5 June 2026 in Medicine
Verified
Journal Article
Open access
JQJingqian Qin
Jingqian Qin
XQXue Qiu
Xue Qiu
BLBin Liang
Bin Liang
YCYongyu Chen
Yongyu Chen
TJTao Jiang
Tao Jiang
The mediating role of inflammatory biomarkers in the association between diabetes and sarcopenia remains poorly quantified in general populations. This study aims to investigate this relationship and quantify the mediating effects of systemic inflammatory indicators. This cross-sectional study included 11,190 adults from the National Health and Nutrition Examination Survey 2011 to 2018. Weighted logistic regression and subgroup analyses were used to assess the association between diabetes and sarcopenia, defined by the Foundation for the National Institutes of Health criteria (appendicular skeletal muscle mass/body mass index). Mediation analysis with bootstrapping was performed to evaluate the mediating roles of white blood cells, neutrophils, lymphocytes, neutrophil-to-lymphocyte ratio, and Systemic Immune-Inflammation Index. Diabetes was significantly associated with an increased risk of sarcopenia (odds ratio = 1.48, 95% confidence interval: 1.03–2.13, P = .042) after full adjustment. Mediation analysis revealed that white blood cells, neutrophils, lymphocytes, neutrophil-to-lymphocyte ratio, and Systemic Immune-Inflammation Index mediated 28.48%, 26.58%, 7.36%, 6.54%, and 10.17% of this association, respectively (all P < .05). Diabetes is positively associated with sarcopenia risk, partially mediated by systemic inflammation. Readily available inflammatory biomarkers may aid in identifying high-risk diabetic patients for sarcopenia prevention.